Category:C-Class pharmacology articles
 | Administrators: Please do not delete this category as empty! This category may be empty occasionally or even most of the time. |
 FA |  A |  GA | B | C | Start | Stub | FL | List | Category | Disambig | Draft | File | Portal | Project | Redirect | Template | NA | ??? |
| 11 | 0 | 49 | 624 | 1,378 | 4,326 | 7,207 | 1 | 434 | 1,147 | 13 | 28 | 44 | 0 | 23 | 942 | 388 | 16 | 0 |
Pages in category "C-Class pharmacology articles"
The following 200 pages are in this category, out of approximately 1,378 total. This list may not reflect recent changes.
(previous page) (next page)O
- Talk:Operation Julie
- Talk:Ophthalmic drug administration
- Talk:Opioid epidemic
- Talk:Opioid epidemic in the United States
- Talk:Opioid use disorder
- Talk:Opipramol
- Talk:Opium in Singapore
- Talk:Oral polio vaccine AIDS hypothesis
- Talk:Oral rehydration therapy
- Talk:Orphan drug
- Talk:Orphan Drug Act of 1983
- Talk:Osanetant
- Talk:Roszaidi Osman
- Talk:Ospemifene
- Talk:Alexander Ostroumov
- Talk:The Other Side of AIDS
- Talk:Over-the-counter drug
- Talk:Oxaliplatin
- Talk:Oxazepam
- Talk:Oxyfedrine
- Talk:Oxygen diffusion-enhancing compound
- Talk:Oxymetholone
P
- Talk:P-i mechanism
- Talk:Paclitaxel
- Talk:Pain management in children
- Talk:Palbociclib
- Talk:Palifermin
- Talk:Pancratistatin
- Talk:Pandemrix
- Talk:Pantoprazole
- Talk:Vassilios Papadopoulos
- Talk:Papain
- Talk:Parasympathomimetic drug
- Talk:Paregoric
- Talk:Pargyline
- Talk:Paromomycin
- Talk:Party and play
- Talk:Patient-reported outcome
- Talk:Martin Paul (professor)
- Talk:Pavlovian-instrumental transfer
- Talk:Pazopanib
- Talk:PDE5 inhibitor
- Talk:PEGylation
- Talk:Pelareorep
- Talk:Pembrolizumab
- Talk:Pemoline
- Talk:Penicillamine
- Talk:Pentamidine
- Talk:Pentazocine
- Talk:Giancarlo Pepeu
- Talk:Peripherally acting μ-opioid receptor antagonist
- Talk:Perphenazine
- Talk:The Perth Group
- Talk:Pertussis vaccine
- Talk:Pertuzumab/trastuzumab/hyaluronidase
- Talk:PetMed Express
- Talk:Pexastimogene devacirepvec
- Talk:Phage therapy
- Talk:Pharmaceutical industry in Gujarat
- Talk:Pharmaceutical industry in India
- Talk:Pharmaceutical industry in the United Kingdom
- Talk:Pharmaceutical marketing
- Talk:Pharmacist
- Talk:Pharmacocybernetics
- Talk:Pharmacodynamics
- Talk:Pharmacoepigenetics
- Talk:Pharmacognosy
- Talk:Pharmacokinetics
- Talk:Pharmacological cardiotoxicity
- Talk:Pharmacology
- Talk:Pharmacology of antidepressants
- Talk:Pharmacomicrobiomics
- Talk:Pharmacotherapy
- Talk:Pharmacy benefit management
- Talk:Pharmacy technician
- Talk:Pharming (genetics)
- Talk:Phencyclidine
- Talk:Phenethylamine
- Talk:Phenmetrazine
- Talk:Phenoxymethylpenicillin
- Talk:Phenprocoumon
- Talk:Phenserine
- Talk:Phentermine
- Talk:Phenylephrine
- Talk:Phenylmercury acetate
- Talk:Phenylpropanolamine
- Talk:Phenylpropylaminopentane
- Talk:Phenytoin
- Talk:Phlotoxin 1
- Talk:Phoratoxin and viscotoxin
- Talk:Phosphatidylserine
- Talk:Phosphodiesterase inhibitor
- Talk:Physiologically based pharmacokinetic modelling
- Talk:Picropodophyllin
- Talk:Pill splitting
- Talk:Piperacillin
- Talk:Piperine
- Talk:Piracetam
- Talk:Pirfenidone
- Talk:Pixantrone
- Talk:Platinum-based antineoplastic
- Talk:Plazomicin
- Talk:Pleconaril
- Talk:Plerixafor
- Talk:Pneumococcal polysaccharide vaccine
- Talk:Pneumococcal vaccine
- Talk:Polymer-protein hybrid
- Talk:Polypharmacy
- Talk:Polystyrene (drug delivery)
- Talk:Polystyrene sulfonate
- Talk:Ponatinib
- Talk:Poppy straw
- Talk:Potassium channel blocker
- Talk:Potion
- Talk:Povidone-iodine
- Talk:Pralidoxime
- Talk:Prasugrel
- Talk:Pravastatin
- Talk:Prazepam
- Talk:Precautionary principle
- Talk:Preclinical development
- Talk:Preclinical imaging
- Talk:Pregnanolone
- Talk:Prescription drug
- Talk:Pridopidine
- Talk:Procainamide
- Talk:Progestogen (medication)
- Talk:Project 523
- Talk:Prokinetic agent
- Talk:Promegestone
- Talk:Promethazine
- Talk:Propylene glycol
- Talk:Propylthiouracil
- Talk:Prostacyclin
- Talk:Prostaglandin EP2 receptor
- Talk:Prostaglandin F2alpha
- Talk:Proteases (medical and related uses)
- Talk:Proteases in angiogenesis
- Talk:Protectin D1
- Talk:Protein kinase C
- Talk:Protein synthesis inhibitor
- Talk:Protide
- Talk:Prulifloxacin
- Talk:Psilocin
- Talk:Psychiatric medication
- Talk:Psychonautics
- Talk:Psychopharmacology revolution
- Talk:Pullulan bioconjugate
- Talk:Purdue Pharma
- Talk:Pyrantel
- Talk:Pyriproxyfen
- Talk:Pyrroloquinoline quinone
Q
R
- Talk:R v Lee
- Talk:Rabies vaccine
- Talk:Radioactive tracer
- Talk:Radium-223
- Talk:Raloxifene
- Talk:Raltegravir
- Talk:Ranitidine
- Talk:Rasagiline
- Talk:Reactogenicity
- Talk:Recombinant human parathyroid hormone
- Talk:RECOVERY Trial
- Talk:Recreational drug use in animals
- Talk:Recreational use of nitrous oxide
- Talk:Reduction-sensitive nanoparticles
- Talk:Regulation of therapeutic goods
- Talk:Relapse
- Talk:Relaxin
- Talk:Remdesivir
- Talk:Renin inhibitor
- Talk:Rowshan Reordan
- Talk:Republic Drug Store
- Talk:Research in multiple sclerosis
- Talk:RET inhibitor
- Talk:Retigabine
- Talk:Reuptake inhibitor
- Talk:Reverse-transcriptase inhibitor
- Talk:Reward system
- Talk:Rexall
- Talk:Ribavirin
- Talk:Rifampicin
- Talk:Rifampicin/isoniazid/pyrazinamide
- Talk:Rifaximin
- Talk:Rintatolimod
- Talk:Rituximab
- Talk:RNA therapeutics
- Talk:RNA-targeting small molecule drugs
- Talk:Roche
- Talk:Ropinirole
- Talk:Rotavirus vaccine
- Talk:Bruce Roth
- Talk:RTI-7470-44
- Talk:Rubella vaccine
- Talk:Barry Rumack
- Talk:Russian Anti-Doping Agency